Genomic instability in repeated sequences is an early somatic event in colorectal tumorigenesis that persists after transformation

1. Bos, J.L. et al. Prevalence of ras gene mutations in human colorectal cancer. Nature 327, 293−297 (1987).
2. Forrester, K., Almoguera, C., Han, K., Grizzle, W.E. & Perucho, M. Detection of high incidence of K-ras oncogenes during human colon tumorigenesis. Nature 327, 298−303 (1987).
3. Baker, S.J. et al. Chromosome 17 deletions and p53 gene mutations in colorectal carcinomas. Science 244, 217−221 (1989).
4. Fearon, E.R. et al. Identification of a chromosome 18q gene that is altered in colorectal cancers. Science 247, 49−56 (1990).
5. Kinzler, K. et al. Identification of FAP locus genes from chromosome 5q21. Science 253, 661−665 (1991).
6. Groden, J. et al. Identification and characterization of the familial adenomatous polyposis coli gene. Cell 66, 589−600 (1991).
7. Fearon, E. & Vogelstein, B. A genetic model for colorectal tumorigenesis. Cell 61, 759−767 (1990).
8. Fearon, E. & Jones, P.A. Progressing toward a molecular description of colorectal cancer development. FASEB J. 6, 2783−2790 (1992).
9. Ionov, J., Peinado, M.A., Malkhosyan, S., Shibata, D. & Perucho, M. Ubiquitous somatic mutations in simple repeated sequences reveal a new mechanism for colonic carcinogenesis. Nature 363, 558−561 (1993).
10. Thibodeau, S., Bren, G. & Schaid, D. Microsatellite instability in cancer of the proximal colon. Science 260, 816−819 (1993).
11. Aaltonen, L.A. et al. Clues to the pathogenesis of familial colorectal cancer. Science 260, 812−816 (1993).
12. Nelson, R.L. & Mason, H.S. An explicit hypothesis for chemical carcinogenesis. J. theor. Biol. 37, 197−200 (1972).
13. Loeb, L.A., Springgate, C.F., & Battula, N. Errors in DNA replication as a basis of malignant changes. Cancer Res. 34, 2311−2321 (1974).
14. Cairns, J. Mutation selection and the natural history of cancer. Nature 255, 197−200 (1975).
15. Lynch, H.T. et al. Hereditary nonpolyposis colorectal cancer (Lynch syndrome I and II). Cancer Genet. Cytogenet. 143, 160−170 (1991).
16. Peltomaki, P. et al. Genetic mapping of a locus predisposing to human colorectal cancer. Science 260, 810−812 (1993).
17. Lindblom, A., Tannergard, P., Werelius, B. & Nordenskjold, M. Genetic mapping of a second locus predisposing to hereditary non-polyposis colon cancer. Nature Genet. 5, 279−282 (1993).
18. Peinado, M.A., Malkhosyan, S., Velazquez, A. & Perucho, M. Isolation and characterization of allelic losses and gains in colorectal tumours by arbitrarily primed polymerasechain reaction. Proc. natn. Acad. Sci. U.S.A. 89, 10065−10069 (1992).
19. Hearne, K.M., Ghosh, S. & Todd, J.A. Microsatellites for linkage analysis of genetic traits. Trends Genet. 8, 288−293 (1992).
20. Weber, J.L. & Wong, C. Mutation of human short tandem repeats. Hum. molec. Genet. 2, 1123−1128 (1993).
21. Strand, M., Prolla, T., Liskay, M.R. & Petes, T.D. Destabilization of tracts of simple repetitive DNA in yeast by mutations affecting DNA mismatch repair. Nature 365, 274−276 (1993).
22. Streisinger, G. et al. Frameshift mutations and the genetic code. Cold Spring Harbor Symp. quant. Biol 31, 77−84 (1966).
23. Richards, R.I. & Sutherland, G.R. Dynamic mutations: A new class of mutations causing human disease. Cell 70, 709−712 (1992).
24. Mandel, J. Questions of expansion. Nature Genet. 4, 8−9 (1993).
25. Shibata, D. et al. Specific genetic analysis of microscopic tissue after Selective Ultraviolet Radiation Fractionation and the Polymerase Chain Reaction. Am. J. Pathol. 141, 1−5 (1992).
26. Shibata, D., Schaeffer, J., Li, Z., Capella, G. & Perucho, M. Genetic heterogeneity of the c-K-ras locus In colorectal adenomas but not adenocarcinomas. J. natn. Cancer Inst. 85, 1058−1063 (1993).
27. Lasko, D., Cavenee, W. & Nordenskjold, M. Loss of constitutional heterozygosity in human cancer. A. Rev. Genetics 25, 281−314 (1991).
28. Pardue, M.L., Instability of Chromosomes and Genomes. Cell 66, 427−431 (1991).
29. Naumova, A. & Sapienza, C. The genetics of retinoblastoma, revisited. Am. J. hum. Genet. (in the press).
30. Ripley, L.S. Frameshift mutations: Determinants of specificity. Ann. Rev. Genet. 24, 189−213 (1990).
31. Fashena, S.J., Reeves, R. & Ruddle, N.H. A poly(dA-dT) upstream activating sequence binds high-mobility group I protein and contributes to lymphotoxin (tumor necrosis factor-B) gene regulation. Molec. Cell. Biol. 12, 894−903 (1992).
32. Foulds, L. The experimental study of tumour progression: A review. Cancer Res. 14, 327−337 (1954).
33. Nowell, P. The clonal evolution of tumour cell populations. Science 194, 23−28 (1976).
34. Brattain, M.G., Fine, W.D., Khaled, F.M., Thompson, J. & Brattain, D.E. Heterogeneity of malignant cells from a human colonic carcinoma. Cancer Res. 41, 1751−1756 (1981).
35. Leith, J.T. & Dexter, D.L. in Mammalian tumour cell heterogeneity 11−22 and 97−120 (CRC Press, Boca Raton, Florida, 1986).
36. Kunkel, T.A. Frameshift mutagenesis by eucaryotic DNA polymerases in vitro. J. biol. Chem. 261, 13581−13587 (1986).
37. Kunkel, T. Biological asymmetries and the fldelity of eukaryotic DNA replication. BioEssays 14, 303−308 (1992).
38. Sinden, R.R. & Wells, R.D. DNA structure, mutations, and human genetic disease. Curr. Op. Biotech. 3, 612−622 (1992).
39. Levinson, G. & Gutman, G.A. Slipped-Strand mispairing: a major mechanism for DNA sequence evolution. Molec. Biol. Evol. 4 (3), 203−221 (1987).
40. Trinh, Q. & Sinden, R.R. Preferential DNA secondary structure mutagenesis in the lagging strand of replication in E. coli. Nature 352, 544−547 (1991).
41. Beckman, J.S. & Weber, J.L. Survey of human and rat microsatellites. Genomics 12, 627−631 (1992).
42. Kem, S.E. Clonality: more than just a tumor-progression model. J. natn. Cancer Inst. 85, 1020−1021 (1993).
43. Lynch, H.T. et al. Flat adenomas in a colon cancer-prone kindred. J. natn. Cancer Inst. 80, 278−282 (1988).
44. Kunkel, T. Slippery DNA and diseases. Nature 365, 207−208 (1993).
45. Welsh, J. & McClelland, M. Fingerprinting genomes using PCR with arbitrary primers. Nucl. Acids Res. 18, 7213−7218 (1990).
46. Mullis, K.B., & Faloona, F.A. Specific synthesis of DNA in vitro via a polymerase catalyzed chain reaction. Meth. Enzymol. 155, 335−350 (1987).
47. Weber, J.L., Kwitek, A.E. & May, P.E. Dinucleotide repeat polymorphisms at the D5S107, D5S11, D5S117 and D5S118 loci. Nucl. Acids Res. 18, 4035 (1990).
48. Weber, J.L., Kwitek, A.E. & May, P.E. Dinucleotide repeat polymorphisms at the D6S87 locus. Nuc. Acid Res. 18, 4636 (1990).
49. Weber, J.L. et al. Dinucleotide repeat polymorphisms at the D17S250 and D17S261 loci. Nuc. Acid Res. 18, 4640 (1990).
50. Leibovitz, A. et al. Classification of human colorectal adenocarcinoma cell lines. Cancer Res. 36, 4562−4569 (1976).
51. Tom, B.H. et al. Human Colonic Adenocarcinoma Cells. I. Establishment and Description of a New Line. In Vitro 12 (13), 180−191 (1976).
52. Peinado, M.A., Fernandez-Renart, M., Capella, G., Wilson, L. & Perucho, M. Mutations in the p53 suppressor gene do not correlate with c-K-ras oncogene mutations in colorectal cancer. Int. J. Oncol. 2, 123−134 (1993).
53. Dexter, D.L., Barbosa, J.A. & Calabresi, P. N, N-dimethylformamide-induced alteration of cell culture characteristics and loss of tumorigenicity in cultured human colon carcinoma cells. Cancer Res. 39, 1020−1025 (1979).
54. Sugarbaker, P., Gunderson, L. & Wittes, R., Colorectal Cancer. In Cancer, principles and practice of oncology. (eds De Vita, V., Hellman, S.& Rosenberg, S.) 814−815 (J. B. Lippincott Co, Philadelphia, 1985).
55. Fishel, R. et al. The human mutatorgene homolog MSH2 and its association with Hereditary Nonpolyposis Colon Cancer. Cell 75, 1027−1038 (1993).
56. Leach, F. et al. Mutations of a mutS homolog in Hereditary Nonpolyposis Colorectal Cancer. Cell 75, 1215−1225 (1993).
57. Parsons, R. et al. Hypermutability and mismatch repair deficiency in RER+ tumor cells. Cell 75, 1227−1236 (1993).

	Top

	Top